Literature DB >> 15230498

The breast cancer related burden of morbidity and mortality in six European countries: the European Disability Weights project.

Michelle E Kruijshaar1, Jan J Barendregt.   

Abstract

BACKGROUND: The burden of breast cancer expressed in Disability Adjusted Life Years (DALYs) was compared for six European countries and its sensitivity to different sources of variation examined.
METHODS: DALYs were calculated using country-specific epidemiological data and European Disability Weights. Epidemiological data for 1996 were obtained for Denmark, England and Wales, France, The Netherlands, Spain and Sweden. Disability weights were empirically derived.
RESULTS: Denmark and The Netherlands lost the largest number of DALYs (approximately 1100 DALYs per 100,000 women). They were followed by England (87% of the Danish burden), France (72%), Sweden (68%) and Spain (67%). 70 to 80% of the burden was caused by mortality. Cross-national variation in disease epidemiology was the largest source of variation in the burden of breast cancer. Variation in disability weights and uncertainty in epidemiological data had smaller effects.
CONCLUSION: To compare the burden of breast cancer and most other types of cancer mortality rates provide sufficient information.

Entities:  

Mesh:

Year:  2004        PMID: 15230498     DOI: 10.1093/eurpub/14.2.141

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  3 in total

1.  Burden of cancer in Serbia.

Authors:  Hristina Vlajinac; Sandra Sipetić-Grujicić; Slavenka Janković; Jelena Marinković; Nikola Kocev; Ljiljana Marković-Denić; Vesna Bjegović
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

2.  Burden of early, advanced and metastatic breast cancer in The Netherlands.

Authors:  G T Vondeling; G L Menezes; E P Dvortsin; F G A Jansman; I R Konings; M J Postma; M H Rozenbaum
Journal:  BMC Cancer       Date:  2018-03-07       Impact factor: 4.430

3.  Burden of disease due to cancer in Spain.

Authors:  Nerea Fernández de Larrea-Baz; Elena Alvarez-Martín; Consuelo Morant-Ginestar; Ricard Gènova-Maleras; Angel Gil; Beatriz Pérez-Gómez; Gonzalo López-Abente
Journal:  BMC Public Health       Date:  2009-01-30       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.